Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)
Clinical trial NCT05629065 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05629065
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-28
- Primary completion
- 2024-09-30
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.